Premium
Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE‐1 in the hybridoma‐induced tumours
Author(s) -
Ji R.C.,
Eshita Y.,
Kato S.
Publication year - 2007
Publication title -
international journal of experimental pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.671
H-Index - 72
eISSN - 1365-2613
pISSN - 0959-9673
DOI - 10.1111/j.1365-2613.2007.00532.x
Subject(s) - lymphatic system , podoplanin , lymphatic endothelium , lymphangiogenesis , pathology , lymphatic vessel , metastasis , chemistry , biology , medicine , cancer , genetics
Summary Tumour‐associated lymphatics contribute to a key component of metastatic spread, however, the biological interaction of tumour cells with intratumoural and peritumoural lymphatics (ITLs and PTLs) has remained unclear. To address this important issue, we have focused on the morphological and molecular aspects of newly formed lymphatics (lymphangiogenesis) and pre‐existing lymphatics in the intratumoural and peritumoural tissues by using a hybridoma‐induced tumour model. In the present study, ITLs with very high vessel density within the tumour mass showed small and flattened contours that varied from non‐solid‐to‐solid tumours, whereas PTLs were relatively disorganized and tortuous, and packed with a cluster of tumour cells at the tumour periphery. Lymphatic endothelial cells (LECs) both in ITLs and PTLs were expressed with LYVE‐1 and podoplanin in various tumour tissues, in which initial lymphatics were extremely extended and dilated. The tumour cells were frequently detected adhering to or penetrating lymphatic walls, especially near the open junctions. In the metastatic tissues, lymphangiogenic vasculatures occurred within the tumour matrix, and collecting PTLs represented abnormal twisty valve leaflets. The Western blot and RT‐PCR analysis showed local variations of LEC proliferating potentials and lymphatic involvement in metastasis by a distinct profile of the protein and mRNA expression by LYVE‐1, podoplanin, Prox‐1 and vascular endothelial growth factor‐3 (VEGFR‐3). These findings indicated that both ITLs and PTLs, including enlarged pre‐existing and newly formed lymphatics, may play a crucial role in metastasis with an active tumour cell adhesion, invasion, migration and implantation.